Scientificamerican iconScientificamericanSep 29, 2026 ~4 min source read

One in eight new cancers linked to infections — many are preventable with testing, treatment and vaccines

A Lancet Oncology analysis estimates infections caused about 2.3 million cancer cases worldwide in 2024 (≈12% of diagnoses). A small number of pathogens account for most of that burden, and established public-health measures can reduce risk.

One in eight new cancers are likely caused by infections—there’s an easy way to protect yourself

Share this story

Send the public story page.

Useful takeaways from this story.

About 2.3 million cancer cases in 2024, roughly 12% of new diagnoses worldwide, were attributed to infections, according to a Lancet Oncology analysis.

Many infection-linked cancers are preventable: screening, antibiotics for H. pylori, and vaccines (HPV, hepatitis B) are proven interventions.

Geographic differences—higher rates in regions such as sub-Saharan Africa—reflect uneven access to screening and prevention programs.

# What the new analysis found

# Which pathogens account for most cases

  • Helicobacter pylori and human papillomavirus (HPV) together accounted for more than 1.5 million estimated cancer cases. H. pylori has long been associated with stomach cancer and, in this analysis, was also linked to a substantial share of bowel cancer cases. HPV causes several cancer types, notably cervical cancer, and is connected to throat and anal cancers.
  • Hepatitis B infection was linked to about 360,000 cancer cases, mainly liver cancer.
  • Epstein-Barr virus (EBV) accounted for around 260,000 cases and was associated with cancers such as nasopharyngeal carcinoma, some lymphomas, and additional stomach cancers identified in more recent research.

# Prevention is practical and evidence-based The study's authors and other cancer researchers emphasize that many of these infection-related cancers are preventable with existing tools.

  • Vaccination: HPV vaccination, introduced in the U.S. in 2006, prevents infections that lead to multiple cancers. In the two decades since its introduction, cervical cancer rates have fallen by more than half in some U.S. states among women aged 20 to 31—the first cohort offered the vaccine as preteens. Hepatitis B vaccination also prevents liver cancer linked to chronic infection.
  • Testing and treatment: Screening and treatment programs for hepatitis C and B can reduce liver cancer risk. Antibiotic treatment of H. pylori infection can lower the chance of developing stomach-related cancers.

# Geographic differences and policy implications The burden of infection-linked cancers is not evenly distributed. The analysis found higher rates in regions such as sub-Saharan Africa. Those differences reflect gaps in investment: fewer cervical cancer screening programs and lower access to vaccines and treatments in some regions increase population risk. Mapping where infection-attributable cancer is concentrated can guide public-health priorities and resource allocation.

# What individuals can do now

  • Get recommended vaccines: HPV and hepatitis B where indicated by age and local guidelines.
  • Follow screening recommendations: cervical cancer screening and liver-related monitoring when at risk.
  • Seek testing and treatment for infections known to elevate cancer risk (for example, H. pylori, hepatitis C) if you have clinical indications or risk factors.

# Bottom line A significant share of the global cancer burden is linked to infections, but many of those cases are preventable through existing public-health measures: vaccination, testing, and treatment. Where prevention programs are scaled and equitably delivered, infection-linked cancer rates decline.

More context around this story.

Loading more related stories...

Keep reading in the app

Open the app view to save this story, compare related coverage, and continue from the same source.

Open in app